Director/PDMR Shareholding.

Craneware plc

(“Craneware” or the “Company”)

Director/ PDMR Shareholding

Vesting of Long Term Incentive Plan Awards and Total Voting Rights

24 September 2026 – The Board of Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, announces that on 22 September 2026, under the terms of the Craneware plc Long Term Incentive Plan (2022) (“LTIP”), conditional awards of ordinary shares of 1p each in the Company (“Shares”) which were granted to three Directors of the Company and to the Company’s Chief Legal Officer, who is also a person discharging managerial responsibility (‘PDMR’), vested to the extent that certain performance conditions were satisfied. 

As noted below, Keith Neilson, CEO of the Company, received 34,113 ordinary shares of 1p each in the Company (“Shares”). Mr. Neilson has chosen to retain the full quantity of Shares from the vesting of this conditional award rather than utilising the Company’s net settlement facility to settle the income tax and national insurance contributions. These represent a total cost to Mr. Neilson of over £196,000 to retain the full award. 

Following the vesting of this conditional award and payment of the associated tax liabilities, Mr. Neilson’s shareholding in the Company has increased to 3,257,658 Ordinary Shares in the capital of the Company, representing 9.48% of the Company’s issued share capital (excluding 1,162,996 Ordinary Shares held in treasury).

*excluding 1,162,996 Ordinary Shares held in treasury.

The net amount of Shares received by the CFO, CPO and the Chief Legal Officer, as shown in the table above, from the vested LTIP awards was after payment of the associated tax liabilities. No consideration was payable by each of these two Directors or by the other PDMR to receive the Shares from these LTIP awards.

The net number of Shares from these vested LTIP awards received by each of the three Directors and the other PDMR are subject to a two year post-vesting holding period.

Following this transaction, Craig Preston holds 111,542 Shares which is 0.324% of the issued share capital* of the Company, Isabel Urquhart holds 25,466 Shares which is 0.074% of the issued share capital* of the Company and Eric Carter holds 39,016 Shares which is 0.113% of the issued share capital* of the Company.  

Total Voting Rights

Following the vesting of these conditional share awards and also the vesting of conditional share awards for certain other employees on 22 September 2026, the Company is transferring or has transferred a total of 142,025 Ordinary Shares previously held in treasury to satisfy the transactions. As a result, the Company’s issued share capital now consists of 35,542,169 Ordinary Shares, of which 1,162,996 remain held in treasury. Accordingly, the total number of Ordinary Shares in the Company with voting rights is 34,379,173. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

PDMR Notification: Keith Neilson

1. Details of the Restricted Person / person closely associated with him or her

a) Name     Keith Neilson

2. Reason for the notification

a) Position / status    CEO

b) Initial notification / Amendment  Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name     Craneware plc

b) LEI      213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument     Ordinary Shares of 1p each in the capital of Craneware plc

b) Identification code    ISIN GB00B2425G68

c) Nature of the transaction Vesting of conditional share award under the Craneware plc Long Term Incentive Plan (2022)

d) Price(s) and volume(s)   Volume(s) 34,113, Price(s) £0

e) Aggregated information:

   i. Aggregated volume  34,113

   ii. Price    £0

f) Date of the transaction    2026-09-22

g) Place of the transaction   Outside a trading venue

PDMR notification: Craig Preston

1. Details of the Restricted Person / person closely associated with him or her

a) Name     Craig Preston

2. Reason for the notification

a) Position / status    CFO

b) Initial notification / Amendment  Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name     Craneware plc

b) LEI     213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument     Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code   ISIN GB00B2425G68

c) Nature of the transaction   1) Vesting of conditional share award under the Craneware plc

       Long Term Incentive Plan (2022)

2) Surrender of Ordinary Shares to satisfy tax liabilities on vesting of conditional share award

d) Price(s) and volume(s)   1) Volume(s) released from vested award 25,356, Price(s) £0

2) Volumes(s) surrendered 14,656, Price(s) £10.35 

e) Aggregated information:

   i. Aggregated volume    1) 25,356

      2) 14,656

   ii. Price(s)   1)  £0

                   2) £10.35

f) Date of the transaction    2026-09-22

g) Place of the transaction   Outside a trading venue

PDMR notification: Isabel Urquhart

1. Details of the Restricted Person / person closely associated with him or her

a) Name     Isabel Urquhart

2. Reason for the notification

a) Position / status    Chief People Officer

b) Initial notification / Amendment  Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name     Craneware plc

b) LEI     213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument     Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code   ISIN GB00B2425G68

c) Nature of the transaction   1) Vesting of conditional share award under the Craneware plc

       Long Term Incentive Plan (2022)

2) Surrender of Ordinary Shares to satisfy tax liabilities on   vesting of conditional share award

d) Price(s) and volume(s)   1) Volume(s) released from vested award 17,429, Price(s) £0

2) Volumes(s) surrendered 10,074, Price(s) £10.35

e) Aggregated information:

  i. Aggregated volume              1) 17,429        

                  2) 10,074

  ii. Price(s)                1) £0

                2) £10.35 

f) Date of the transaction    2026-09-22

g) Place of the transaction   Outside a trading venue

PDMR notification: Eric Carter

1. Details of the Restricted Person / person closely associated with him or her

a) Name     Eric Carter

2. Reason for the notification

a) Position / status    Chief Legal Officer

b) Initial notification / Amendment  Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name     Craneware plc

b) LEI     213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument     Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code   ISIN GB00B2425G68

c) Nature of the transaction   1) Vesting of conditional share award under the Craneware plc

       Long Term Incentive Plan (2022)

 2) Surrender of Ordinary Shares to satisfy tax liabilities on vesting of conditional share award

d) Price(s) and volume(s)   1) Volume(s) released from vested award 14,110, Price(s) £0

       2) Volumes(s) surrendered 3,514, Price(s) £10.35

e) Aggregated information:

  i. Aggregated volume              1) 14,110

                  2) 3,514

  ii. Price(s)                1) £0

                2) £10.35 

f) Date of the transaction    2026-09-22

g) Place of the transaction   Outside a trading venue

For further information, please contact:

Craneware plc        +44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

Alma Strategic Communications (Financial PR)   +44 (0)20 3405 0205

Caroline Forde, Louisa El-Ahwal      [email protected]

Peel Hunt (NOMAD and Joint Broker)      +44 (0)20 7418 8900

Neil Patel, Benjamin Cryer, Kate Bannatyne

Investec Bank PLC (Joint Broker)     +44 (0)20 7597 5970

Patrick Robb, Virginia Bull, Arnav Kapoor

Berenberg (Joint Broker)      +44 (0)20 3207 7800

Mark Whitmore, Tom Ballard, Patrick Dolaghan, Ryan Mahnke

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.

Learn more at www.thecranewaregroup.com